ONOlha Neiko

Olha Neiko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olha Neiko has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ВЗАЄМОЗВ’ЯЗОК МІЖ ГЕСТАЦІЙНИМ ЗБІЛЬШЕННЯМ МАСИ ТІЛА І ГІПЕРТЕНЗИВНИМИ РОЗЛАДАМИ ПІД ЧАС ВАГІТНОСТІ

    by О. М. Куса, Т. Б. Сніжко, Н. І. Геник, І. В. Кравчук, Н. В. Дрогомирецька, Ю. Б. Моцюк, О. В. Нейко

    Gestational hypertension and preeclampsia are among the leading complications of pregnancy associated with an increased risk of maternal and perinatal morbidity and mortality. Scientific sources indicate a relationship between pre-pregnancy body mass index and excessive gestational weight gain (GWG) and the development of hypertensive disorders in pregnant women. Confirmation of this relationship is of great importance, as it is the basis for the development and implementation of preventive strategies in pregnancy management aimed at controlling body weight gain in order to prevent hypertensive complications. The work aimed to establish the relationship between the level of GWG and the development and course of gestational hypertension and preeclampsia in normotensive women. Special attention was paid to assessing the impact of the dynamics of body weight gain during the trimesters on the likelihood of these complications. There were examined 125 women – the first group included 31 pregnant women with the development of gestational hypertension, the second group – 43 with preeclampsia, the control group had 51 women with physiological pregnancy. GWG was assessed in each trimester and throughout pregnancy. The average age of women was (29.7±4.2) years (95 % CI 28.0-31.4) without a significant difference in the groups. There were 63.2 % primiparous women, 36.8 % with repeated delivery. Statistical analysis was performed based on Microsoft Excel and "Statistica 12.0" (StatSoft Inc., USA). The average initial body weight of women in the first group was (53.99±2.40) kg, in the second group – (62.51±3.30) kg, without a statistically significant difference with the control group (54.43±2.81) kg (in both cases p>0.05). At the end of pregnancy, excessive GWG was diagnosed in 1.8 (p<0.05) and 2.5 times (p<0.001) more percent of patients, respectively, in the first and second groups compared with the proportion of pregnant women with recommended body weight gain. Excessive GWG increased the chances of developing gestational hypertension (OR=3.31; 95 % CI: 1.17–9.36; p<0.05) and preeclampsia (OR=6.67; 95 % CI: 2.60–17.30; p<0.001). In patients with preeclampsia in the three trimesters, the average body weight was higher compared to the control group, with the highest rates of weight gain in the second and third trimesters. The appearance of symptoms of gestational hypertension up to 34 weeks was 2 times more common, and preeclampsia was 2.7 times more common in pregnant women with excessive GWG compared to the recommended one, and 5.6 and 2.7 times more common in women with the disease after 34 weeks, respectively (in all cases p<0.05). Excessive GWG increases the chances of developing gestational hypertension up to 34 weeks and early preeclampsia ((OR=6.80; 95% CI: 1.23–37.50; p<0.05) and (OR=6.30; 95 % CI: 1.39–28.46; p<0.05, respectively)), developing severe preeclampsia (OR=10.31; 95 % CI: 1.18–89.86; p<0.05) compared to the recommended GWG. With excessive GWG, the rate of delivery up to 37 weeks with gestational hypertension was 5.1 times and with preeclampsia 5.0 times higher compared to patients in the control group (in both cases p<0.05). The results have scientific significance for developing effective strategies for controlling body weight during pregnancy from early stages, which helps minimize the risk of developing hypertensive disorders in pregnant women with normal body mass index before pregnancy.

  • Open Access

    Optimization of treatment and prevention of recurrences of bacterial vaginosis in postmenopausal women

    by S.O. Ostafiichuk, N.V. Drogomyretska, O.M. Kusa, O.V. Neiko, I.V. Levitsky, N.M. Kinash

    The study aimed to improve the effectiveness of treatment and prevention of recurrences of bacterial vaginosis (BV) in postmenopausal women. 87 women with BV aged 50 to 65 who received a course of antibacterial therapy with control clinical and laboratory recovery were examined. In the future, two groups were selected: the first group (42 women) received probiotics in suppositories (live lactobacillus strains L. aktobacillus plantarum 8P-A3 or L. plantarum 38, or L. fermentum 90T-C4, or L. fermentum 39) vaginally 2 times a day for 10 days. Women of the second group (45 patients) received probiotics vaginally once a day for 20 days and a suppository with estriol 0.5 mg vaginally once a day for 2 weeks, and then 2 times a week for 3 months. Evaluation of effectiveness was carried out after 3 and 6 months. A gynecological examination, determination of the pH reaction of vaginal contents, aminotest, microscopy of vaginal smears, bacteriological cultures on nutrient media for the determination of facultatively anaerobic bacteria, Gardnerella vaginalis, quantitative analysis of vaginal microflora, species composition and frequency of lactobacilli were performed. In the women of the first group, the risk of recurrence of the laboratory criteria of BV increases after 3 months: an increase in the pH of the vaginal contents by 1.2 times (p<0.05), the appearance of a positive aminotest in 38.1% of patients, the presence of Gardnerella vaginalis in 26.2% women with a pathological number of 104-105 CFU/ml, regression of the pool of lactobacilli with worsening of the situation and the appearance of clinical manifestations of the disease after 6 months. In the second group, there was a decrease in cases of recovery of laboratory markers after 3 months and clinical and laboratory criteria of BV after 6 months. The study proves the necessity of determining the laboratory criteria for the diagnosis of BV in dynamics 3 months after the main course of antimicrobial therapy in women without a clinical picture of recurrence. The effectiveness of intravaginal use of probiotics and vaginal estriol at a dose of 0.5 mg for the treatment and prevention of BV recurrences in postmenopausal women with a long course has been shown (4 months).

  • Open Access

    LEPTIN AND VISFATIN AS PREDICTORS OF GESTATIONAL HYPERTENSIVE COMPLICATIONS IN OVERWEIGHT WOMEN

    by Natalia Henyk, Ruslana Bihun, Lesya Maksymenko, Svitlana Ostafiichuk, Oksana Perhulyn, Olha Neiko, Ihor Levitskyi, Natalia Kinash

    Background. Over the past decades, fatty tissue has ceased to be just an energy depot, but as a source of hormone-like peptides - adipokines, such as leptin and visfatin. There is a direct correlation between body weight and the risk of developing gestational complications. Aim of this study was to determine prognostic value of leptin and visfatin in predicting gestational hypertensive complications in overweight women. Materials and methods. We examined 117 women divided into two groups: the main group included 68 overweight women, the control group included 49 women with normal body weight. Serum leptin and visfatin was established before pregnancy, in the first and third trimester. Results. In overweight women, gestational hypertension was observed in 20 women (29.4%) and preeclampsia in 25 women (36.8%). The concentration of leptin in the third trimester during gestational hypertension increased by 21.9%, by 20.2% in preeclampsia compared before pregnancy (p<0.05) and exceeded the value in uncomplicated pregnancy by 1.3 times (p<0.05). In main group during third trimester in case of gestational hypertensive complications, the concentration of visfatin was higher than in women without complications (p<0.05). In the groups of women with hypertensive conditions, we observed significantly higher concentrations of visfatin compared with the woman without complications. In main group in case of gestational hypertensive complications, the concentration of visfatin was higher than in women without complications on the third trimester. Conclusions. In overweight patients who developed hypertensive complications, leptin found to be 3.0 times higher before pregnancy and 2.0 times higher in the first trimester. Visfatin were found to be 1.2 times higher at both stages compared with control group. Leptin and visfatin may serve as qualitative predictors of hypertensive complications before pregnancy and during early gestation in overweight women.


  • Open Access

    CHARACTERISTICS OF LABOR IN WOMEN WITH PATHOLOGICAL GESTATIONAL WEIGHT gain

    by S.O. Ostafiichuk, O.V. Neіko, O.M. Kusa, I.V. Levitsky, N.M. Kinash

    Prepregnancy maternal body mass index (BMI) and gestational weight gain (GWG) are strongly correlated with pregnancy outcomes. The studies of the mode of delivery reveal the importance of implementing preventive measures to influence women's body weight at the preconceptional stage and during pregnancy.Aim. To study the characteristics of labor in women depending on the prepregnancy body weight and the level of weight gain during pregnancy.Materials and methods. A prospective study was carried out at the Ivano-Frankivsk City Clinical Perinatal Center, Ukraine. 219 pregnant women were enrolled to the study: 153 (69.9 %) with normal initial BMI, 18 (8.2 %) – insufficient, 23 (10.5 %) – excessive, and 25 (11.4 %) with obesity. 100 (45.7 %) women had recommended GWG, 45 (20.5 %) – insufficient, 74 (33.8 %) – excessive. Pre-pregnancy weight status of patients was assessed with BMI (kilogram/ meter2) calculated from pre-pregnancy weight and height. A statistical analysis package based on Microsoft Excel and the "Statistica 12.0" program (StatSoft Inc., USA) were used. The differences between the selections were considered statistically reliable at p<0,05.Results. All women have delivered at full-term pregnancy in (39.2±1.1) weeks (95% CI 39.2-39.6). Excessive BMI and excessive GWG were associated with an increased frequency of complications during labor and delivery. However, it was diagnosed that the cases of complicated labors in excessive BMI pregnant were statistically significant in women with a GWG pathological deviating from the recommended one. In pregnant women with excessive BMI and obesity, the frequency of emergency cesarean sections increased significantly, by 2.7 times (p<0.05) and 3.0 times (p<0.05), respectively. Excessive GWG increased the chances of cesarean section (χ2=3.86, p<0.05) and (χ2=4.50, p<0.05), induced labor (χ2=5.74, p<0 .05) and (χ2=4.92, p<0.05), respectively, in overweight and obesity women, uterine contraction abnormalities (χ2=3.86, p<0.05), and oxytocin administration (χ2=4.70, p<0.05) in overweight. In pregnant women with a normal BMI, an excessive GWG was associated with an increased risk of caesarean section (χ2=7.73, p<0.01), uterine dystocia (χ2=6.42, p<0.05), mother's birth canal soft tissue traumas (χ2=5.82, p<0.05), induced labor (χ2=4.14, p<0.05), episio-/perineotomy (χ2=4.49, p0.05). Резюме. Мета: Вивчити особливості перебігу пологів у жінок в залежності від вихідної маси тіла та рівня збільшенням маси тіла під час вагітності. Матеріали і методи: Обстежено 219 вагітних, з яких 153 (69,9 %) були з нормальним індексом маси тіла (ІМТ), 18 (8,2 %) – з недостатнім, 23 (10,5 %) – з надмірним та 25 (11,4 %) з ожирінням. У 100 (45,7 %) жінок діагностовано рекомендоване гестаційне збільшення маси тіла (ГЗМТ), у 45 (20,5 %) – недостатнє, у 74 (33,8 %) – надлишкове. Використовували пакет статистичного аналізу на базі Microsoft Excel та програми «Statistica 12.0» (StatSoft Inc.,USA). Результати: Випадки ускладненого перебігу пологів при надмірному ІМТ статистично значущі у жінок з патологічним ГЗМТ. Надлишкове ГЗМТ підвищує шанси кесаревого розтину (χ2=3,86, р<0,05) та (χ2=4,50, р<0,05), індукованих пологів (χ2=5,74, р<0,05) та (χ2=4,92, р<0,05) відповідно у вагітних з вихідною надмірною вагою та ожирінням, аномалій скоротливої діяльності матки (χ2=3,86, р<0,05) і введення окситоцину в пологах (χ2=4,70, р<0,05) при надмірній масі тіла. У вагітних з нормальним ІМТ надлишкове ГЗМТ асоціюється з підвищеним ризиком кесаревого розтину (χ2=7,73, р<0,01), аномалій скоротливої діяльності матки (χ2=6,42, р<0,05), розривів м’яких тканин пологових шляхів матері (χ2=5,82, р<0,05), довенної стимуляції пологової діяльності (χ2=4,14, р<0,05), проведенням епізіо-/перінеотомії (χ2=4,49, р<0,05). Висновки: Зростання частоти ускладнень під час пологів, виявлені в групі вагітних з надмірним ІМТ статистично значущі у жінок з надлишковим ГЗМТ. У вагітних з недостатнім ГЗМТ не виявлено достовірної різниці у частоті ускладнень в пологах порівняно з групою з рекомендованою надбавкою в вазі.Перебіг пологів у вагітних з надлишковою масою тіла і патологічним гестаційним збільшенням маси тіла (ГЗМТ) у більшості випадків є ускладненим. Дослідження за цією проблемою є актуальними, оскільки розкривають важливість впровадження заходів впливу на масу тіла жінок на етапі підготовки до вагітності та під час гестаційного періоду. Мета: Вивчити...

  • Open Access

    THE ROLE OF HYPERLEPTINEMIA IN THE GENESIS OF GESTATIONAL HYPERTENSION AND PREECLAMPSIA

    by Svitlana Ostafiichuk, Nataliia Drohomyretska, Yuliia Motsyuk, Olha Neіko, Natalia Henyk

    The aim of the study was to determine the association of serum leptin levels in pregnant women with the risk of hypertensive disorders depending on gestational weight gain (GWG). We have studied 190 pregnant women with a normal pre-pregnancy body mass index, who were registered at the City Clinical Perinatal Center, Ivano-Frankivsk, Ukraine. Quantitative determination of leptin in serum was performed by ELISA Kit (CAN-L-4260, Canada). Statistical analyses based on Microsoft Excel statistical analysis package and Statistica 6.0. Gestational hypertension (GH) has developed in 29 (15.3 %), preeclampsia in 39 (20.5 %) cases and 122 (64.2%) pregnant were normotensive. The recommended GWG (11.5-16.0 kg) was diagnosed in 133 (70.0 %), excessive in 57 (30.0 %) patients. The frequency of GH was 2.2-fold (p<0.05) and preeclampsia was 4.2-fold (p<0.001) higher in pregnant with excessive GWG, compared to patients with the recommended GWG. Leptin concentrations in pregnant with GH were 1.5-fold in the third trimester (p<0.01), and with preeclampsia 1.1-fold in the second (p<0.01) and 1.5-fold in the third (p<0.01) trimesters higher compared to normotensive women. Serum leptin concentrations of pregnant with GH and preeclampsia were significantly higher in the group with excessive GWG compared to the recommended, which were detected in the second trimester. A high degree of risk of hyperleptinemia in the groups of pregnant with GH (OR=3.50; 95%CI: 1.48-9.33; p<0.05), and with preeclampsia (6.01; 2.43-15.02) was found in women with excessive GWG. A positive correlation was found between leptin concentration, GWG and body fat percentage in pregnant with GH and preeclampsia in the second and third trimesters. Thus, leptin can be considered a marker of the association between pathological GWG and hypertensive disorders in pregnancy